Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 12, 2017
Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia
Daniela Di Marcantonio, Esteban Martinez, Simone Sidoli, et al.
Cell Death & Disease
|
June 17, 2022
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia
Anna Montanaro, Samuel Kitara, Elisa Cerretani, et al.
Annals of Hematology
|
July 18, 2025
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design
Valerio De Stefano, Francesco Passamonti, Francesca Palandri, et al.
Cancer
|
April 1, 2021
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome
Francesca Palandri, Mario Tiribelli, Massimo Breccia, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 12, 2017
Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia
Daniela Di Marcantonio, Esteban Martinez, Simone Sidoli, et al.
Cell Death & Disease
|
June 17, 2022
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia
Anna Montanaro, Samuel Kitara, Elisa Cerretani, et al.
Annals of Hematology
|
July 18, 2025
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design
Valerio De Stefano, Francesco Passamonti, Francesca Palandri, et al.
Cancer
|
April 1, 2021
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome
Francesca Palandri, Mario Tiribelli, Massimo Breccia, et al.
Page
of 4